TGFB1 and colorectal carcinoma: 68Ga-FAPI PET/CT imaging assists in selecting patients with metastatic CRC who can benefit from immunotherapy, guiding precise scheduling of TGF-β inhibition to optimize the combination strategy with immunotherapy.